Ultrastructural demonstration of mast cells in varicose veins of lower limbs: Presence of mast cell-mediated mechanism

Journal of Cardiovascular Surgery

Volumn 38, Issue 5, 1997, Pages 443-446

  Yamada, T ^a,c   Yamamoto, H ^d   Ogawa, A ^b   Miyazaki, K ^c   Tokunaga, O ^b   Itoh, T ^d  

^a Dept Thorac and Cardiovasc Surg ^*  (Japan)

^b Pathology   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d Yamamoto Surgical Hospital   (Japan)

Author keywords

Mast cells; Saphenous veins, ultrastructure; Varicose veins pathology

Indexed keywords

COLLAGEN;

ADULT; AGED; ARTICLE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGRANULATION; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; LEG VEIN; LYMPHOCYTE; MALE; MAST CELL; MEDIATOR; SAPHENOUS VEIN; VARICOSIS;

ADULT; AGED; FEMALE; HUMANS; MALE; MAST CELLS; MIDDLE AGED; SAPHENOUS VEIN; VARICOSE VEINS;

EID: 0030780160     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Johnson G Jr, Rutherford RB. Varicose veins: patient selection and treatment. In: Rutherford RB, editor. Vascular surgery. 4th edition. Philadelphia: W.B. Saunders Company, 1995:1825-8.
2. Cherry KJ, Jr, Hollier LH. Varicose veins. In: Haimovici H, editor. Haimovici's vascular surgery. Principles and techniques. 3rd edition. San Meteo: Appleton & Lange, 1989:922-8.
3. Cornu-Thenard A, Boivin P, Baud J, Vincenzi ID, Carpentier PH. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol 1994; 20:318-26.
4. Haimovici H. Role of precapillary arteriovenous shunting in the pathogenesis of varicose veins and its therapeutic implications. Surgery 1987;101:515-22.
5. Baron HC, Cassaro S. The role of arteriovenous shunts in the pathogenesis of varicose veins. J Vasc Surg 1986;4:124-8.
6. Clarke GH, Vasdekis SN, Hobbs JT, Nicolaides AN. Venous wall function in the pathogenesis of varicose veins. Surgery 1992; 111:402-8.
7. Jurukova Z, Milenkov C. Ultrastructural evidence for collagen degradation in the walls of varicose veins. Exp Mol Pathol 1982;37:37-47.
8. Rose SS, Ahmed A. Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg 1986;27:534-43.
9. Haynes DF, Kerstein MD, Roberts MP. Increased prostacyclin and thromboxane A2 formation in human varicose veins. J Surg Res 1990;49:228-32.
10. Crotty TP. Is circulating noradrenaline the cause of varicose veins? Med Hypotheses 1991;34:243-51.
11. Forman MB, Oates JA, Robertson D, Robertson RM, Roberts II LJ, Virmani R. Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med 1985;313:1138-41.
12. Kolodgie FD, Virmani R, Cornhill JF, Herderick EE, Smialek J. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cardiol 1991; 17:1553-60.
13. Atkinson JB, Harlan CW, Harlan GC, Virmani R. The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. Hum Pathol 1994;25:154-9.
14. Cross KS, El-Sanadiki MN, Murray JJ, Mikat EM, McCann RL, Hagen P. Mast cell infiltration: A possible mechanism for vein graft vasospasm. Surgery 1988;104:171-7.
15. Yamada T, Tomita S, Mori M, Sasatomi E, Suenaga E, Itoh T. Increased mast cell infiltration in varicose veins of the lower limbs: a possible role in the development of varices. Surgery 1996;119:in press.
16. Schwartz LB, Austen KF. Structure and function of the chemical mediators of mast cells. In: Ishizaka K, editor. Mast cell activation and mediator release. Progress in allergy. Basel: S. Karger AG, 1984:271-321.
17. Schwartz LB, Lewis RA, Seldin D, Austen KF. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol 1981;126:1290-4.
18. Katsunuma N, Kido H. Biological functions of serine proteases in mast cells in allergic inflammation. J Cell Biochem 1988;38:291-301.
19. Valent P, Bettelheim P. Cell surface structures on human basophils and mast cells: biochemical and functional characterization. In: Dixon FJ, editor. Advances in immunology. San Diego: Academic Press, Inc, 1992;52:333-423.
20. Enerbäck L, Norrby K. The mast cells. In: Iversen OH, editor. Current topics in pathology. Cell kinetics of the inflammatory reaction. Berlin: Springer-Verlag. 1989;79:169-204.
21. Whitaker-Menezes D, Schechter NM, Murphy GF. Serine proteinases are regionally segregated within mast cell granules. Lab Invest 1995;72:34-41.
22. Yamada T, Fan J, Shimokama T, Tokunaga O, Watanabe T. Induction of fatty streak-like lesions in vitro using a culture model system simulating arterial intima. Am J Pathol 1992;141:1435-44.
23. Mitchell MB, Rutherford RB, Krupski WC. Infrarenal aortic aneurysms. In: Rutherford RB, editor. Vascular surgery. 4th edition. Philadelphia: W.B. Saunders Company. 1995:1032-60.
24. Prescott MF, McBride CK, Court M. Development of intimai lesions after leukocyte migration into the vascular wall. Am J Pathol 1989;135:835-46.
25. Barker SGE, Tilling LC, Miller GC et al. The adventitia and atherogenesis: removal initiates intimai proliferation in the rabbit which regresses on generation of a "neoadventitia". Atherosclerosis 1994;105:131-44.
26. Levi-Schaffer F, Austen KF, Gravallese PM, Stevens RL. Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. Proc Natl Acacl Sci USA 1986;83:6485-8.
27. Ihle JN, Keller J, Oroszlan S. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, P cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. J Immunol 1983;131:282-7.
28. v genotype. J Cell Physiol 1988;134:78-84.
29. Hültner L, Moeller J, Schmitt E. Thiol-sensitive mast cell lines derived from mouse bone marrow respond to a mast cell growth-enhancing activity different from both IL-3 and IL-4. J Immunol 1989;142:3440-6.
30. Reed JA, Albino AP, McNutt NS. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995;72:215-22.
31. Qu Z, Liebler JM, Powers MR. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995;147:564-73.
32. Gonzalez A-M, Buscaglia M, Fox R et al. Basic fibroblast growth factor in Dupuytren's contracture. Am J Pathol 1992; 141:661-71.
33. Henke C, Marineili W, Jessurun J. Macrophage production of basic fibroblast growth factor in trie fibroproliferative disorder of alveolar fibrosis after lung injury. Am J Pathol 1993;143:1189-99.
34. Charlotte F, Win KM, Preaux AM. Immunolocalization of heparin-binding growth factors (HBGF) types 1 and 2 in rat liver: selective hyperexpression of HBGF-2 in carbon tetrachloride-induced fibrosis. J Pathol 1993;169:471-6.